New drugs for HDL-C disorders: the beginning.

Abstract:

:For more than 20 years there has been increasing interest in the development of novel therapies to raise levels of high-density lipoprotein cholesterol (HDL-C). However, well publicized failures of recent clinical trials of agents that raise HDL-C levels have stimulated considerable controversy with regard to the potential clinical utility of this therapeutic target. A number of classes of agents are currently under investigation with variable effects on HDL quantity and quality. These will be reviewed.

journal_name

Curr Med Chem

authors

Duong M,Nicholls SJ

doi

10.2174/0929867321666140414104130

subject

Has Abstract

pub_date

2014-01-01 00:00:00

pages

2947-51

issue

25

eissn

0929-8673

issn

1875-533X

pii

CMC-EPUB-60084

journal_volume

21

pub_type

杂志文章,评审
  • Pharmacotherapy of borderline personality disorder: a systematic review for publication purpose.

    abstract::Borderline Personality Disorder (BPD) is a common disorder in psychiatric practice and drugs are widely used in its treatment, targeting symptom clusters, such as affective dysregulation, impulsive-behavioural dyscontrol, and cognitive-perceptual symptoms. In last period, a growing number of studies on pharmacological...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986711796504682

    authors: Bellino S,Rinaldi C,Bozzatello P,Bogetto F

    更新日期:2011-01-01 00:00:00

  • Antisynthetase syndrome: a review of etiopathogenesis, diagnosis and management.

    abstract::Antisynthetase syndrome is a group of closely related rare diseases which clinically manifest with inflammatory myopathies, interstitial lung disease, inflammatory arthritis, skin hyperkeratosis (mechanic’s hands) and Raynaud phenomenon. The pathophysiology of antisynthetase syndrome is not entirely understood, but ge...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章

    doi:

    authors: Mirrakhimov AE

    更新日期:2015-05-13 00:00:00

  • Chemokines and breast cancer: a gateway to revolutionary targeted cancer treatments?

    abstract::Breast cancer is an example of a solid tumour which is well treated in the early stages of disease by surgical excision, but once metastatic spread has occurred, medical therapies (chemotherapy and radiotherapy) are highly toxic, expensive and palliative. It is known that certain tumours exhibit specific patterns of m...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867033457944

    authors: Dowsland MH,Harvey JR,Lennard TW,Kirby JA,Ali S

    更新日期:2003-04-01 00:00:00

  • Stimuli-responsive Carriers for Controlled Intracellular Drug Release.

    abstract:BACKGROUND:Stimuli-responsive carriers are a class of drug delivery systems which can change their physicochemical properties and/or structural conformations in response to specific stimuli. Although passive and active drug targeting has proved to reduce the side effects to normal cells, controlled intracellular drug r...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867324666170830102409

    authors: Sheng Y,Hu J,Shi J,Lee LJ

    更新日期:2019-01-01 00:00:00

  • Recent advances in DAPYs and related analogues as HIV-1 NNRTIs.

    abstract::HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs) nowadays represent most promising anti-AIDS drugs that specifically inhibit HIV-1 reverse transcriptase (RT). They have a unique antiviral potency, high specificity and low cytotoxicity. However, to a great extent, the efficacy of HIV-1 NNRTIs is compounde...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986711794839142

    authors: Chen X,Zhan P,Li D,De Clercq E,Liu X

    更新日期:2011-01-01 00:00:00

  • Target-based drug discovery for malaria, leishmaniasis, and trypanosomiasis.

    abstract::Advances in combinatorial chemistry, high-throughput screening, and molecular modeling have revolutionized the process of drug discovery in the pharmaceutical industry. Drug discovery efforts for the primary protozoal parasitic diseases of the developing world, malaria, leishmaniasis, and trypanosomiasis, have also be...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867003374615

    authors: Werbovetz KA

    更新日期:2000-08-01 00:00:00

  • miRNA: small molecules as potential novel biomarkers in cancer.

    abstract::Four different types of small RNAs functionally associated with gene silencing have been discovered in animals including small interfering RNAs (siRNAs), microRNAs (miRNAs), and Piwi-interacting RNAs (piRNAs). Experimental evidence suggests that miRNAs regulate the expression of more than 30% of protein-coding genes. ...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986710794182980

    authors: Shah AA,Leidinger P,Blin N,Meese E

    更新日期:2010-01-01 00:00:00

  • N-acetyl-cysteine in Schizophrenia: Potential Role on the Sensitive Cysteine Proteome.

    abstract:BACKGROUND:N-acetyl-cysteine (NAC) has shown widespread utility in different psychiatric disorders, including a beneficial role in schizophrenic patients. Although the replenishment of glutathione and the antioxidant activity of NAC have been suggested as the mechanisms that improve such a wide range of disorders, none...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867326666191015091346

    authors: Martínez-Banaclocha M

    更新日期:2020-01-01 00:00:00

  • Anti-cancer therapeutic approaches based on intracellular and extracellular heat shock proteins.

    abstract::Stress or heat shock proteins (Hsps) Hsp90, Hsp70 and Hsp27 are chaperones that assist the proteins in their folding, stability, assembly into multi-protein complexes and transport across cellular membranes. The expression of some of them is highly induced in response to a wide variety of physiological and environment...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986707782360079

    authors: Didelot C,Lanneau D,Brunet M,Joly AL,De Thonel A,Chiosis G,Garrido C

    更新日期:2007-01-01 00:00:00

  • The Role and Mechanism of Thiol-Dependent Antioxidant System in Bacterial Drug Susceptibility and Resistance.

    abstract::Antibiotics play an irreplaceable role in the prevention and treatment of bacterial infection diseases. However, because of the improper use of antibiotics, bacterial resistance emerges as a major challenge of public health all over the world. The small thiol molecules such as glutathione can directly react and conjug...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章

    doi:10.2174/0929867326666190524125232

    authors: Ouyang Y,Li J,Peng Y,Huang Z,Ren Q,Lu J

    更新日期:2020-01-01 00:00:00

  • Signaling through RAS-RAF-MEK-ERK: from basics to bedside.

    abstract::Aberrant signaling caused by mutations in the RAS-RAF-MEK-ERK pathway and its upstream activators critically contributes to human tumor development. Strategies, which aim at inhibiting hyperactive signaling molecules, appear conceptually straight forward, but their translation into clinical practice has been hampered ...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986707780059670

    authors: Zebisch A,Czernilofsky AP,Keri G,Smigelskaite J,Sill H,Troppmair J

    更新日期:2007-01-01 00:00:00

  • Shutting Down the Furnace: Preferential Killing of Cancer Cells with Mitochondrial-Targeting Molecules.

    abstract::Mitochondria are organelles which play an important role not only in cellular metabolism but also in controlling pathways related with cell death, ionic and redox regulation. Alterations in mitochondrial metabolism are implicated in a variety of diseases, including cancer. Cellular and mitochondrial metabolism are bot...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867322666150209155957

    authors: Deus CM,Santos GL,Loureiro R,Vega-Naredo I,Faneca H,Oliveira PJ

    更新日期:2015-01-01 00:00:00

  • Thiol proteins, redox modulation and parenchymal lung disease.

    abstract::The lung is a unique organ in terms of its direct exposure to high levels of oxygen and reactive compounds. Several parenchymal lung diseases (e.g. emphysema associated with smoking and a number of fibrotic lung disorders) have been proposed to be due to the exposure of the lung to exogenous irritants leading to local...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986707779313345

    authors: Kinnula VL,Vuorinen K,Ilumets H,Rytilä P,Myllärniemi M

    更新日期:2007-01-01 00:00:00

  • Conjugation of peptides to antisense interleukin-6 via click chemistry.

    abstract::Low molecular weight oligonucleotides have been discovered to have potential use for gene therapy by selectively inhibiting the expression of certain genes. Chemical conjugation of functional peptides to oligonucleotides can introduce desired properties to the oligonucleotides, such as cell-specific delivery, cellular...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章

    doi:10.2174/0929867320666131119125045

    authors: Wang CF,Auriola S,Hirvonen J,Santos HA

    更新日期:2014-04-01 00:00:00

  • Phenylpropanoid sucrose esters: plant-derived natural products as potential leads for new therapeutics.

    abstract::Natural products are regarded as vital key source of lead compounds for drug discovery due to their structural diversity and broad array of biological activities. Phenylpropanoid sucrose esters are naturally occurring compounds isolated from various plants and are structurally characterized by a sucrose core connected...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986711796391589

    authors: Panda P,Appalashetti M,Judeh ZM

    更新日期:2011-01-01 00:00:00

  • Aptamers as therapeutics in cardiovascular diseases.

    abstract::With many advantages over other therapeutic agents such as monoclonal antibodies, aptamers have recently emerged as a novel and powerful class of ligands with excellent potential for diagnostic and therapeutic applications. Typically generated through Systematic Evolution of Ligands by EXponential enrichment (SELEX), ...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986711797189673

    authors: Wang P,Yang Y,Hong H,Zhang Y,Cai W,Fang D

    更新日期:2011-01-01 00:00:00

  • Modulating apoptosis: current applications and prospects for future drug development.

    abstract::Agents modulating apoptosis are of extraordinary promise for the treatment of several states of disease including cancer, AIDS, neurodegenerative and ischemic diseases. In this review a brief summary of cellular pathways relevant to programmed cell death first is given and potential therapeutic targets therein are emp...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:

    authors: Deigner HP,Kinscherf R

    更新日期:1999-05-01 00:00:00

  • Combining Drug and Psychological Treatments for Obsessive- Compulsive Disorder: What is the Evidence, When and for Whom.

    abstract:BACKGROUND:Serotonin reuptake inhibitors (SRIs) and cognitive-behavioral psychotherapy (CBT) are first-line treatments for obsessive-compulsive disorder (OCD). Since response is often inadequate, in recent years researchers investigated whether combining CBT and SRIs, either ab initio or sequentially, results in a grea...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867324666170712114445

    authors: Albert U,Di Salvo G,Solia F,Rosso G,Maina G

    更新日期:2018-01-01 00:00:00

  • Intravenous and regional paclitaxel formulations.

    abstract::Paclitaxel has been proven to be effective against different types of cancer. A delivery system loaded with paclitaxel at tumor site should provide a high local concentration of the drug detrimental to malignant cells, which prevents the re-growth and metastasis of tumor. In this review, paclitaxel formulations for sy...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867043455981

    authors: Pawar R,Shikanov A,Vaisman B,Domb AJ

    更新日期:2004-02-01 00:00:00

  • Cancer stem cells: a new paradigm for understanding tumor growth and progression and drug resistance.

    abstract::Normal somatic stem cells (SC) are naturally resistant to chemotherapeutic agents due to their expression of various membrane transporter molecules (such as MDR-1), detoxifying enzymes and DNA repair proteins. In addition, they also have a slow rate of cell turnover and therefore escape from chemotherapeutic agents th...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986709788186147

    authors: Gangemi R,Paleari L,Orengo AM,Cesario A,Chessa L,Ferrini S,Russo P

    更新日期:2009-01-01 00:00:00

  • Signal Transduction Pathways as Therapeutic Target for Chagas Disease.

    abstract::Trypanosomatids are a group of flagellated unicellular eukaryotes, causing serious human diseases including Chagas disease (Trypanosoma cruzi), sleeping sickness (Trypanosoma brucei spp.) and Leishmaniasis (Leishmania spp.). The second messenger cAMP is involved in numerous and fundamental processes in these parasites...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867326666190620093029

    authors: Schoijet AC,Sternlieb T,Alonso GD

    更新日期:2019-01-01 00:00:00

  • State of the art of the therapeutic perspective of sorafenib against hematological malignancies.

    abstract::The bi-aryl urea multi-kinase inhibitor Sorafenib (BAY 43-9006, Nexavar) was initially approved for the treatment of unresectable hepatocellular carcinoma and advanced renal cell carcinoma. Eleven years after its first description in PubMed, the therapeutic potential of Sorafenib has been evaluated in an increasing nu...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986712803341548

    authors: Zauli G,Voltan R,Tisato V,Secchiero P

    更新日期:2012-01-01 00:00:00

  • Syntheses and antitumor activities of potent inhibitors of ribonucleotide reductase: 3-amino-4-methylpyridine-2-carboxaldehyde-thiosemicarba-zone (3-AMP), 3-amino-pyridine-2-carboxaldehyde-thiosemicarbazone (3-AP) and its water-soluble prodrugs.

    abstract::The reductive conversion of ribonucleotides to deoxyribonucleotides by ribonucleotide reductase (RR) is a crucial and rate-controlling step in the pathway leading to the biosynthesis of DNA, since deoxyribonucleotides are present in extremely low levels in mammalian cells. Mammalian ribonucleotide reductase (RR) is co...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867013373741

    authors: Li J,Zheng LM,King I,Doyle TW,Chen SH

    更新日期:2001-02-01 00:00:00

  • Recent Advances in Multi-target Drugs Targeting Protein Kinases and Histone Deacetylases in Cancer Therapy.

    abstract::Protein Kinase Inhibitors (PKIs) and Histone Deacetylase Inhibitors (HDACIs) are two important classes of anticancer agents and have provided a variety of small molecule drugs for the treatment of various types of human cancers. However, malignant tumors are of a multifactorial nature that can hardly be "cured" by tar...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章

    doi:10.2174/0929867327666200102115720

    authors: Ling Y,Liu J,Qian J,Meng C,Guo J,Gao W,Xiong B,Ling C,Zhang Y

    更新日期:2020-01-01 00:00:00

  • Developmental regulated expression of anti- and pro-apoptotic BCL-2 family genes during human early embryonic development.

    abstract::Apoptotic cell death has been reported in human oocytes and preimplantation embryos under in vivo and in vitro conditions. BCL-2 family proteins comprise both anti- and pro-apoptotic members, which are likely to play a key role in controlling oocyte and early embryo survival. However, very limited data are available o...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章

    doi:10.2174/09298673113206660278

    authors: Boumela I,Assou S,Haouzi D,Déchaud H,Aït-Ahmed O,Hamamah S

    更新日期:2014-01-01 00:00:00

  • Preterm labour: an overview of current and emerging therapeutics.

    abstract::Preterm labour is a major cause of perinatal mortality and morbidity. However, during the past 40 years of clinical studies and despite the use of multiple therapeutic agents, the rate of preterm birth has not drastically declined. In 1991, it was estimated that in the US approximately 116,000 women admitted with acut...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867033457331

    authors: Schwarz MK,Page P

    更新日期:2003-08-01 00:00:00

  • Triglyceride-Rich Lipoproteins as a Source of Proinflammatory Lipids in the Arterial Wall.

    abstract::Apolipoprotein B -containing lipoproteins include triglyceride-rich lipoproteins (chylomicrons and their remnants, and very low-density lipoproteins and their remnants) and cholesterol-rich low-density lipoprotein particles. Of these, lipoproteins having sizes below 70-80 nm may enter the arterial wall, where they acc...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867325666180530094819

    authors: Öörni K,Lehti S,Sjövall P,Kovanen PT

    更新日期:2019-01-01 00:00:00

  • Atrial remodeling and novel pharmacological strategies for antiarrhythmic therapy in atrial fibrillation.

    abstract::Atrial fibrillation (AF) is the most common arrhythmia in clinical practice. It can occur at any age, however, it becomes extremely common in the elderly, with a prevalence approaching more than 20% in patients older than 85 years. AF is associated with a wide range of cardiac and extra-cardiac complications and there...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986711796642373

    authors: Jost N,Kohajda Z,Kristóf A,Kovács PP,Husti Z,Juhász V,Kiss L,Varró A,Virág L,Baczkó I

    更新日期:2011-01-01 00:00:00

  • Phosphodiesterase 10 Inhibitors - Novel Perspectives for Psychiatric and Neurodegenerative Drug Discovery.

    abstract:BACKGROUND:The phosphodiesterase 10 (PDE10) family, identified in 1999, is mainly expressed in the brain, particularly in the striatum, within the medium spiny neurons, nucleus accumbens, and olfactory tubercle. Inhibitors of PDE10 (PDE10-Is) are a conceptually rational subject for medicinal chemistry with potential us...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867325666180309110629

    authors: Zagorska A,Partyka A,Bucki A,Gawalskax A,Czopek A,Pawlowski M

    更新日期:2018-01-01 00:00:00

  • New Tracers and New Perspectives for Molecular Imaging in Lewy Body Diseases.

    abstract::The term Lewy body diseases (LBDs) refers to a subset of neurodegenerative disorders that share the accumulation of the so-called Lewy bodies (LB) including: Parkinson's disease (PD), dementia with Lewy bodies (DLB), and PD later characterized by the occurrence of dementia (PDD). Moreover, multiple system atrophy (MSA...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867324666170609080000

    authors: Bauckneht M,Arnaldi D,Nobili F,Aarsland D,Morbelli S

    更新日期:2018-01-01 00:00:00